AU2003220786A1 - Orodispersible pharmaceutical composition comprising agomelatine - Google Patents
Orodispersible pharmaceutical composition comprising agomelatineInfo
- Publication number
- AU2003220786A1 AU2003220786A1 AU2003220786A AU2003220786A AU2003220786A1 AU 2003220786 A1 AU2003220786 A1 AU 2003220786A1 AU 2003220786 A AU2003220786 A AU 2003220786A AU 2003220786 A AU2003220786 A AU 2003220786A AU 2003220786 A1 AU2003220786 A1 AU 2003220786A1
- Authority
- AU
- Australia
- Prior art keywords
- agomelatine
- pharmaceutical composition
- orodispersible pharmaceutical
- orodispersible
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N Agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title 1
- 229960002629 agomelatine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0200792A FR2834890B1 (en) | 2002-01-23 | 2002-01-23 | ORODISPERSIBLE PHARMACEUTICAL COMPOSITION OF AGOMELATIN |
| FR0200792 | 2002-01-23 | ||
| PCT/FR2003/000197 WO2003061644A1 (en) | 2002-01-23 | 2003-01-22 | Orodispersible pharmaceutical composition comprising agomelatine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003220786A1 true AU2003220786A1 (en) | 2003-09-18 |
| AU2003220786B2 AU2003220786B2 (en) | 2007-08-02 |
Family
ID=27589556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003220786A Ceased AU2003220786B2 (en) | 2002-01-23 | 2003-01-22 | Orodispersible pharmaceutical composition comprising agomelatine |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US20050131071A1 (en) |
| EP (1) | EP1467724B1 (en) |
| JP (2) | JP4335011B2 (en) |
| KR (1) | KR100605798B1 (en) |
| CN (1) | CN1287780C (en) |
| AR (1) | AR038207A1 (en) |
| AT (1) | ATE324882T1 (en) |
| AU (1) | AU2003220786B2 (en) |
| BR (1) | BRPI0307072B1 (en) |
| CA (1) | CA2473201C (en) |
| CY (1) | CY1105415T1 (en) |
| DE (1) | DE60304993T2 (en) |
| DK (1) | DK1467724T3 (en) |
| EA (1) | EA007299B1 (en) |
| ES (1) | ES2262999T3 (en) |
| FR (1) | FR2834890B1 (en) |
| GE (1) | GEP20063818B (en) |
| HK (1) | HK1076742A1 (en) |
| MA (1) | MA27101A1 (en) |
| MX (1) | MXPA04007198A (en) |
| NO (1) | NO333712B1 (en) |
| NZ (1) | NZ533843A (en) |
| PL (1) | PL204937B1 (en) |
| PT (1) | PT1467724E (en) |
| SI (1) | SI1467724T1 (en) |
| UA (1) | UA77752C2 (en) |
| WO (1) | WO2003061644A1 (en) |
| ZA (1) | ZA200405153B (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2834889B1 (en) * | 2002-01-18 | 2004-04-02 | Roquette Freres | SOLID ORODISPERSIBLE PHARMACEUTICAL FORM |
| US20030228370A1 (en) * | 2002-06-11 | 2003-12-11 | Michel Serpelloni | Orodispersible solid pharmaceutical form |
| AR047553A1 (en) * | 2003-07-04 | 2006-01-25 | Lundbeck & Co As H | THE COMBINATION OF A SEROTONINE AND AGOMELATINE REABSORTION INHIBITOR |
| FR2884714B1 (en) * | 2005-04-20 | 2011-05-06 | Servier Lab | USE OF AGOMELATIN FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF BIPOLAR DISORDERS |
| FR2890564B1 (en) * | 2005-09-09 | 2007-10-19 | Servier Lab | NOVEL ASSOCIATION BETWEEN AGOMELATIN AND AN INHIBITOR OF NORADRENALINE RECAPTURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT |
| FR2890562B1 (en) * | 2005-09-09 | 2012-10-12 | Servier Lab | USE OF AGOMELATIN FOR THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF SLEEP DISORDERS IN DEPRESSED PATIENTS |
| FR2894475B1 (en) * | 2005-12-14 | 2008-05-16 | Servier Lab | ORODISPERSIBLE PHARMACEUTICAL COMPOSITION FOR OROMUCOSAL OR SUBLINGUAL ADMINISTRATION OF AGOMELATIN |
| EP1849459A1 (en) * | 2006-03-06 | 2007-10-31 | Teva Pharmaceutical Industries Ltd. | Ezetimibe compositions |
| CN101206200B (en) * | 2006-12-19 | 2011-12-28 | 北京德众万全药物技术开发有限公司 | HPLC method for isolation analysis of agomelatine intermediate body and finished product thereof |
| US7608737B2 (en) * | 2007-05-01 | 2009-10-27 | Concert Pharmaceuticasl Inc. | Naphthyl(ethyl)acetamides |
| EP2359813A1 (en) * | 2010-02-04 | 2011-08-24 | Ratiopharm GmbH | Pharmaceutical composition comprising N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamid |
| CN101836966A (en) * | 2010-05-27 | 2010-09-22 | 北京万全阳光医药科技有限公司 | Agomelatine-containing orally disintegrating tablet |
| CN102579415B (en) * | 2011-01-14 | 2014-11-05 | 成都康弘药业集团股份有限公司 | Agomelatine-containing medicinal composition for oral mucosa or sublingual administration |
| AR084865A1 (en) | 2011-01-17 | 2013-07-10 | Takeda Pharmaceutical | FAST DISINTEGRATION PREPARATION, DISPERSABLE COMPRESSED BY ORAL ROUTE |
| US8426461B2 (en) | 2011-01-17 | 2013-04-23 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
| WO2012130837A1 (en) * | 2011-03-28 | 2012-10-04 | Ratiopharm Gmbh | Solid agomelatine in non-crystalline form |
| FR2978916B1 (en) * | 2011-08-10 | 2013-07-26 | Servier Lab | SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN |
| EP2562151A1 (en) * | 2011-08-25 | 2013-02-27 | Dr. Reddy's Laboratories Ltd. | Processes for the preparation of agomelatine and its intermediates |
| EP2765985A1 (en) | 2011-10-14 | 2014-08-20 | Takeda Pharmaceutical Company Limited | Orally dispersible tablet |
| CN103169669B (en) * | 2011-12-26 | 2015-06-17 | 中国人民解放军军事医学科学院毒物药物研究所 | Agomelatine covered pellet and drug composition capable of being dispersed in mouth |
| EP2872129B1 (en) | 2012-07-16 | 2017-03-08 | ratiopharm GmbH | Complex of agomelatine and cyclodextrin |
| CN102988315B (en) * | 2012-09-28 | 2017-11-17 | 浙江华海药业股份有限公司 | The preparation method of agomelatine solid preparation |
| FR3001894A1 (en) * | 2013-02-08 | 2014-08-15 | Servier Lab | SOLID PHARMACEUTICAL COMPOSITION FOR BUCCAL ADMINISTRATION OF AGOMELATIN |
| EP2810647A1 (en) | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
| ES2645223T3 (en) | 2013-06-06 | 2017-12-04 | Zentiva, K.S. | Agomelatine formulations comprising agomelatine in the form of co-crystals |
| CN103816129B (en) * | 2014-02-27 | 2020-04-28 | 浙江华海药业股份有限公司 | Agomelatine orally disintegrating tablet |
| CN104586797A (en) * | 2015-01-05 | 2015-05-06 | 万特制药(海南)有限公司 | Agomelatine dispersible tablet and preparation method thereof |
| CN106333929A (en) * | 2016-09-24 | 2017-01-18 | 万特制药(海南)有限公司 | Agomelatine-containing dispersible tablet and preparation method thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3505433A1 (en) * | 1985-02-16 | 1986-08-21 | Basf Ag, 6700 Ludwigshafen | DIRECT TABLETING AIDS |
| DE3506276C1 (en) * | 1985-02-22 | 1986-04-24 | Meggle Milchindustrie Gmbh & Co Kg, 8094 Reitmehring | Direct tableting |
| FR2658818B1 (en) * | 1990-02-27 | 1993-12-31 | Adir Cie | NOVEL DERIVATIVES WITH NAPHTHALENIC STRUCTURE, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
| FR2710265B1 (en) * | 1993-09-22 | 1995-10-20 | Adir | Bioadhesive pharmaceutical composition for the controlled release of active ingredients. |
| NZ278678A (en) * | 1994-01-31 | 1998-03-25 | Yamanouchi Pharma Co Ltd | Compressed moulded tablet with quick disintegration/dissolution in the mouth, mixture of low and high moldable saccharides as carriers |
| HU224035B1 (en) * | 1996-05-13 | 2005-05-30 | Novartis Consumer Health S.A. | Buccal delivery system |
| US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
| NZ507271A (en) * | 1998-03-06 | 2003-03-28 | Eurand Internat S | Fast disintegrating tablets |
| JP2000273039A (en) * | 1999-01-20 | 2000-10-03 | Taisho Pharmaceut Co Ltd | Composition disintegrable in oral cavity |
| ES2292414T3 (en) * | 2000-07-27 | 2008-03-16 | Roquette Freres | ALMIDON AND LACTOSE BASED GRANULES. |
| UA80393C2 (en) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix |
| FR2834889B1 (en) * | 2002-01-18 | 2004-04-02 | Roquette Freres | SOLID ORODISPERSIBLE PHARMACEUTICAL FORM |
-
2002
- 2002-01-23 FR FR0200792A patent/FR2834890B1/en not_active Expired - Fee Related
-
2003
- 2003-01-22 EA EA200400928A patent/EA007299B1/en not_active IP Right Cessation
- 2003-01-22 EP EP03731733A patent/EP1467724B1/en not_active Expired - Lifetime
- 2003-01-22 WO PCT/FR2003/000197 patent/WO2003061644A1/en active IP Right Grant
- 2003-01-22 ES ES03731733T patent/ES2262999T3/en not_active Expired - Lifetime
- 2003-01-22 CN CNB038027100A patent/CN1287780C/en not_active Expired - Fee Related
- 2003-01-22 AT AT03731733T patent/ATE324882T1/en active
- 2003-01-22 AR ARP030100178A patent/AR038207A1/en unknown
- 2003-01-22 DE DE60304993T patent/DE60304993T2/en not_active Expired - Lifetime
- 2003-01-22 KR KR1020047011351A patent/KR100605798B1/en not_active IP Right Cessation
- 2003-01-22 JP JP2003561589A patent/JP4335011B2/en not_active Expired - Fee Related
- 2003-01-22 SI SI200330266T patent/SI1467724T1/en unknown
- 2003-01-22 PL PL370160A patent/PL204937B1/en unknown
- 2003-01-22 UA UA20040806965A patent/UA77752C2/en unknown
- 2003-01-22 US US10/502,593 patent/US20050131071A1/en not_active Abandoned
- 2003-01-22 NZ NZ533843A patent/NZ533843A/en not_active IP Right Cessation
- 2003-01-22 GE GE5625A patent/GEP20063818B/en unknown
- 2003-01-22 PT PT03731733T patent/PT1467724E/en unknown
- 2003-01-22 AU AU2003220786A patent/AU2003220786B2/en not_active Ceased
- 2003-01-22 DK DK03731733T patent/DK1467724T3/en active
- 2003-01-22 MX MXPA04007198A patent/MXPA04007198A/en active IP Right Grant
- 2003-01-22 CA CA2473201A patent/CA2473201C/en not_active Expired - Fee Related
- 2003-01-22 BR BRPI0307072A patent/BRPI0307072B1/en not_active IP Right Cessation
-
2004
- 2004-06-28 ZA ZA2004/05153A patent/ZA200405153B/en unknown
- 2004-07-12 MA MA27775A patent/MA27101A1/en unknown
- 2004-08-18 NO NO20043441A patent/NO333712B1/en not_active IP Right Cessation
-
2005
- 2005-10-10 HK HK05108935A patent/HK1076742A1/en not_active IP Right Cessation
-
2006
- 2006-06-30 CY CY20061100898T patent/CY1105415T1/en unknown
-
2009
- 2009-01-20 JP JP2009010024A patent/JP2009137994A/en active Pending
-
2010
- 2010-06-22 US US12/803,250 patent/US20100260840A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003220786A1 (en) | Orodispersible pharmaceutical composition comprising agomelatine | |
| HK1076742A1 (en) | Orodispersible pharmaceutical composition comprising agomelatine | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| HK1076743A1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| IL172814A0 (en) | Novel solid pharmaceutical composition comprising amisulpride | |
| HK1076741A1 (en) | Orodispersible pharmaceutical composition comprising ivabradine | |
| EP1425019A4 (en) | Pharmaceutical composition | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| AU2002302147A1 (en) | Pharmaceutical composition | |
| AU2002364468A1 (en) | Solid orally-dispersible pharmaceutical formulation | |
| AU2003215706A1 (en) | Orodispersible pharmaceutical composition comprising ivabradine | |
| AU2003215708A1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| AU2003284460A1 (en) | Medicinal composition | |
| AU2003280799A1 (en) | Medicinal composition | |
| AU2003274655A1 (en) | Pharmaceutical compositions containing venlafaxine | |
| AU2003289782A1 (en) | Valproic acid analogues and pharmaceutical compositions thereof | |
| AU2003258772A1 (en) | Novel neutracetical and pharmaceutical compositions and their uses | |
| AU2003280678A1 (en) | Medicinal composition | |
| AUPR529701A0 (en) | Pharmaceutical composition | |
| AUPS188302A0 (en) | Pharmaceutical composition | |
| AU2003219239A1 (en) | Orodispersible pharmaceutical composition comprising mitiglinide | |
| AU2003219238A1 (en) | Orodispersible pharmaceutical composition comprising testosterone | |
| SI1467750T1 (en) | Orodispersible pharmaceutical composition comprising perindopril | |
| AU2002335161A1 (en) | Medicinal composition | |
| AU2003238900A1 (en) | Pharmaceutical formulation |